Authors:
ARAVANTINOS G
FOUNTZILAS G
KOSMIDES P
STATHOPOULOS GP
PAVLIDIS N
DIMOPOULOS MA
BAFALOUKOS D
PAPAKOSTAS P
PAPADIMITRIOU C
NIKOLAIDES G
SKARLOS DV
Citation: G. Aravantinos et al., COMBINATION PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL WITH ALTERNATING CARBOPLATIN AND CISPLATIN AS FIRST LINE TREATMENT FOR ADVANCED OVARIAN-CANCER (AOC), Annals of oncology, 9, 1998, pp. 316-316
Authors:
AGIOSTRATIDOU G
SGOUROS J
GALANI E
BOULGARI A
JANNINIS J
ARAVANTINOS G
SAMANTAS E
SKARLOS DV
GONOS E
Citation: G. Agiostratidou et al., IN-VITRO CHEMOSENSITIVITY AND CORRELATION WITH MOLECULAR ANALYSIS ANDCLINICAL OUTCOME IN PATIENTS WITH OVARIAN OR BREAST-CANCER, Annals of oncology, 9, 1998, pp. 599-599
Authors:
AABO K
ADAMS M
ADNITT P
ALBERTS DS
ATHANAZZIOU A
BARLEY V
BELL DR
BIANCHI U
BOLIS G
BRADY MF
BRODOVSKY HS
BRUCKNER H
BUYSE M
CANETTA R
CHYLAK V
COHEN CJ
COLOMBO N
CONTE PF
CROWTHER D
EDMONSON JH
GENNATAS C
GILBEY E
GORE M
GUTHRIE D
KAYE SB
LAING AH
LANDONI F
LEONARD RC
LEWIS C
LIU PY
MANGIONI C
MARSONI S
MEERPOHL H
OMURA GA
PARMAR MKB
PATER J
PECORELLI S
PRESTI M
SAUERBREI W
SKARLOS DV
SMALLEY RV
SOLOMON HJ
STEWART LA
STURGEON JFG
TATTERSALL MHN
WHARTON JT
HUININK WWT
TOMIROTTI M
TORRI W
TROPE C
TURBOW MM
VERMORKEN JB
WEBB MJ
WILBUR DW
WILLIAMS CJ
WILTSHAW E
YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
Authors:
ARAVANTINOS G
SKARLOS DV
KOSMIDIS P
ATHANASSIADES A
BAFALOUKOS D
GIANNAKAKIS T
KARPATHIOS S
FOUNTZILAS G
Citation: G. Aravantinos et al., A PHASE-II STUDY OF PACLITAXEL IN PLATINUM PRETREATED OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 33(1), 1997, pp. 160-163
Authors:
SKARLOS DV
ARAVANTINOS G
LINARDOU E
KOSTAKOPOULOS CA
KASTRIOTIS I
CHRISTODOULOU C
PICRAMENOS D
GIANNAKAKIS T
DIMOPOULOS K
FOUNTZILAS G
Citation: Dv. Skarlos et al., CHEMOTHERAPY WITH METHOTREXATE, VINBLASTINE, EPIRUBICIN AND CARBOPLATIN (CARBO-MVE) IN TRANSITIONAL-CELL UROTHELIAL CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European urology, 31(4), 1997, pp. 420-427
Authors:
SKARLOS DV
ARAVANTINOS G
KOSMIDIS P
ATHANASSIADIS A
STATHOPOULOS GP
PAVLIDIS N
BAFALOUKOS D
KARPHATHIOS S
PAPAKOSTAS P
BAMIA C
FOUNTZILAS G
Citation: Dv. Skarlos et al., PACLITAXEL WITH CARBOPLATIN VERSUS PACLITAXEL WITH CARBOPLATIN ALTERNATING WITH CISPLATIN AS FIRST-LINE CHEMOTHERAPY IN ADVANCED EPITHELIALOVARIAN-CANCER - PRELIMINARY-RESULTS OF A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Seminars in oncology, 24(5), 1997, pp. 57-61
Authors:
SKARLOS DV
ARAVANTINOS G
KOSMIDIS P
PAVLIDIS N
GENNATAS K
BEER M
MYLONAKIS N
MAKRANTONAKIS P
KLOUVAS G
KARPATHIOS S
LINARDOU H
KONSTANTARAS C
FOUNTZILAS G
Citation: Dv. Skarlos et al., CARBOPLATIN ALONE COMPARED WITH ITS COMBINATION WITH EPIRUBICIN AND CYCLOPHOSPHAMIDE IN UNTREATED ADVANCED EPITHELIAL OVARIAN-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 32A(3), 1996, pp. 421-428
Authors:
MALAMITSI J
ZORZOS J
VARVARIGOU AD
ARCHIMANDRITIS S
DASSIOU C
SKARLOS DV
DIMITRIOU P
LIKOURINAS M
ZIZI A
PROUKAKIS C
Citation: J. Malamitsi et al., IMMUNOLOCALIZATION OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER WITHINTRAVESICALLY ADMINISTERED TC-99M LABELED HMFG1 MONOCLONAL-ANTIBODY, European journal of nuclear medicine, 22(1), 1995, pp. 25-31
Authors:
ZORAS J
ZIZI A
BAKIRAS A
PECTASIDIS D
SKARLOS DV
ZORZOS H
ELEMENOGLOU J
LIKOURINAS M
Citation: J. Zoras et al., EXPRESSION OF A CELL-SURFACE ANTIGEN RECOGNIZED BY THE MONOCLONAL-ANTIBODY AUA1 IN BLADDER-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, European urology, 28(3), 1995, pp. 251-254
Authors:
SKARLOS DV
SAMANTAS E
KOSMIDIS P
FOUNTZILAS G
ANGELIDOU M
PALAMIDAS P
MYLONAKIS N
PROVATA A
PAPADAKIS E
KLOUVAS G
THEOCHARIS D
PANOUSAKI E
BOLETI E
SPHAKIANOUDIS G
PAVLIDIS N
Citation: Dv. Skarlos et al., RANDOMIZED COMPARISON OF ETOPOSIDE-CISPLATIN VS ETOPOSIDE-CARBOPLATINAND IRRADIATION IN SMALL-CELL LUNG-CANCER - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Annals of oncology, 5(7), 1994, pp. 601-607
Authors:
KOSMIDIS P
MYLONAKIS N
SKARLOS DV
SAMANTAS E
BEER M
THEOCHARIS D
ZACHARIADIS E
GIOTI A
PAPADAKIS E
POULAKIS N
PARASTATIDIS S
FOUNTZILAS G
Citation: P. Kosmidis et al., A COMPARATIVE-STUDY OF CISPLATIN AND VINBLASTINE VERSUS IFOSFAMIDE, CISPLATIN AND VINBLASTINE IN NON-OPERABLE NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 5(2), 1994, pp. 159-162
Authors:
ARCHIMANDRITIS SC
MALAMITSI J
BELKAS E
VARVARIGOU AD
COTSYFAKIS K
SIVOLAPENKO G
ZORZOS J
SKARLOS DV
PROUKAKIS C
Citation: Sc. Archimandritis et al., 99M-TECHNETIUM LABELING OF A TUMOR-ASSOCIATED MURINE MONOCLONAL-ANTIBODY FOR IMMUNOSCINTIGRAPHIC STUDIES IN MAN, Journal of labelled compounds & radiopharmaceuticals, 34(4), 1994, pp. 323-337
Authors:
ZORZOS J
SKARLOS DV
POZATZIDOU P
ZIZI A
BAKIRAS A
KORITSIADIS S
PECTASIDIS D
KOUTSIOUMBA P
EPENETOS AA
LIKOURINAS M
Citation: J. Zorzos et al., IMMUNOSCINTIGRAPHY WITH IODINE-131-LABELED MONOCLONAL-ANTIBODY AUA1 IN PATIENTS WITH TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Urological research, 22(5), 1994, pp. 323-327
Authors:
ZORZOS J
SKARLOS DV
EPENETOS AA
PECTASIDES D
KOUTSIOUMBA P
ELEMENOGLOU J
BAKIRAS A
LIKOURINAS M
DIMOPOULOS K
Citation: J. Zorzos et al., INTRAVESICAL ADMINISTRATION OF TUMOR-ASSOCIATED MONOCLONAL-ANTIBODY AUA1 IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - A STUDY OF BIODISTRIBUTION, Urological research, 21(6), 1993, pp. 435-438